Capital raise · Specialty Chemicals

Specialty Chemicals Family Office Capital Raise: An Independent Sponsor's Counsel

Independent sponsor counsel for specialty chemicals, focused on Family Office Capital Raise and the deal mechanics that protect sponsor economics and LP alignment.

EV range $15M to $200M EV EBITDA $3M to $28M Audience Independent Sponsor
The deal context

The economics on a specialty chemicals platform deal usually hinge on a handful of structural decisions. Family Office Capital Raise is one of them.

The typical specialty chemicals platform sits at $15M to $200M EV with EBITDA in the $3M to $28M range. The thesis runs on niche formulator or contract manufacturing buy-up. The IP lives in the formulator's head as often as in the company. Structure for that risk explicitly.

The moves

How Family Office Capital Raise actually gets structured.

  1. Lead with the deal and the structure, not with the firm pitch. Family offices invest in deals first.

  2. Build a Reg D 506(b) or 506(c) deck depending on whether you have a pre-existing relationship.

  3. Confirm accredited or qualified-purchaser status before sharing transactional detail.

  4. Match the LP's preferred check size to the position you can offer in the deal.

  5. In specialty chemicals, layer in chemical inventory transfer filed as part of the Family Office Capital Raise workstream.

The common mistake

Pitching family offices the same way you pitch institutional PE. They want shorter conversations and tighter alignment, not a fund deck.

Jason's take
"Family offices are not small institutions. They are sophisticated buyers of single positions. Pitch accordingly."
Jason Powell · Family Office Capital Raise
Capital after close

The deal is one thing. The capital that opens up after close is another.

Capital after close is where the IRR actually gets made. The right introductions at month nine through month thirty are where this practice works as hard as it does at the LOI.

MONTH 18
Senior refi
MONTH 24
Dividend recap
MONTH 36
Growth equity
YEAR 4–5
Strategic exit
ENGAGE THE PRACTICE

Family Office Capital Raise for Specialty Chemicals, on independent sponsor terms.

Independent sponsor counsel that already speaks fluent deal-by-deal economics, structures clean LPAs, and travels with capital markets relationships for what comes after close.